DK0776323T3 - Salte af et indolderivat mod migræne - Google Patents

Salte af et indolderivat mod migræne

Info

Publication number
DK0776323T3
DK0776323T3 DK95922465.0T DK95922465T DK0776323T3 DK 0776323 T3 DK0776323 T3 DK 0776323T3 DK 95922465 T DK95922465 T DK 95922465T DK 0776323 T3 DK0776323 T3 DK 0776323T3
Authority
DK
Denmark
Prior art keywords
salts
indole derivative
migraine
migraine indole
derivative
Prior art date
Application number
DK95922465.0T
Other languages
Danish (da)
English (en)
Inventor
Valerie Denise Harding
Ross James Macrae
Ronald James Ogilvie
Original Assignee
Pfizer Ltd
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10760474&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0776323(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Ltd, Pfizer Res & Dev filed Critical Pfizer Ltd
Application granted granted Critical
Publication of DK0776323T3 publication Critical patent/DK0776323T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Reciprocating, Oscillating Or Vibrating Motors (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
DK95922465.0T 1994-08-27 1995-05-17 Salte af et indolderivat mod migræne DK0776323T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9417310A GB9417310D0 (en) 1994-08-27 1994-08-27 Therapeutic agents

Publications (1)

Publication Number Publication Date
DK0776323T3 true DK0776323T3 (da) 1998-03-30

Family

ID=10760474

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95922465.0T DK0776323T3 (da) 1994-08-27 1995-05-17 Salte af et indolderivat mod migræne

Country Status (45)

Country Link
US (2) US6110940A (zh)
EP (1) EP0776323B1 (zh)
JP (1) JP2904588B2 (zh)
KR (1) KR100228952B1 (zh)
CN (1) CN1066727C (zh)
AP (1) AP576A (zh)
AT (1) ATE163182T1 (zh)
AU (1) AU691005B2 (zh)
BG (1) BG61840B1 (zh)
BR (1) BRPI9503812B1 (zh)
CA (1) CA2198599C (zh)
CO (1) CO4410334A1 (zh)
CZ (1) CZ287693B6 (zh)
DE (1) DE69501620T2 (zh)
DK (1) DK0776323T3 (zh)
DZ (1) DZ1923A1 (zh)
EG (1) EG23822A (zh)
ES (1) ES2112650T3 (zh)
FI (1) FI113768B (zh)
GB (1) GB9417310D0 (zh)
GR (1) GR3026475T3 (zh)
HR (1) HRP950460B1 (zh)
HU (1) HU227822B1 (zh)
IL (1) IL115013A (zh)
IS (1) IS1850B (zh)
LV (1) LV11800B (zh)
MA (1) MA23650A1 (zh)
MX (1) MX9701538A (zh)
MY (1) MY113733A (zh)
NO (1) NO311297B1 (zh)
NZ (1) NZ288210A (zh)
OA (1) OA10600A (zh)
PE (1) PE41596A1 (zh)
PL (1) PL180867B1 (zh)
RO (1) RO116400B1 (zh)
RU (1) RU2159241C2 (zh)
SA (1) SA95160156B1 (zh)
SI (1) SI9520091B (zh)
SK (1) SK282922B6 (zh)
TN (1) TNSN95092A1 (zh)
TR (1) TR199501061A2 (zh)
UA (1) UA45980C2 (zh)
WO (1) WO1996006842A1 (zh)
YU (1) YU49287B (zh)
ZA (1) ZA957142B (zh)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9420529D0 (en) 1994-10-12 1994-11-30 Pfizer Ltd Indoles
GB9706089D0 (en) * 1997-03-24 1997-05-14 Scherer Ltd R P Pharmaceutical composition
CA2292673C (en) * 1997-07-03 2003-04-22 Pfizer Inc. Pharmaceutical compositions containing eletriptan hemisulphate
GB9714081D0 (en) * 1997-07-03 1997-09-10 Pfizer Ltd Pharmaceutical compositions
GB9816556D0 (en) * 1998-07-30 1998-09-30 Pfizer Ltd Therapy
GB9825988D0 (en) * 1998-11-27 1999-01-20 Pfizer Ltd Indole derivatives
GB9922963D0 (en) * 1999-09-28 1999-12-01 Pfizer Ltd Polymorphic salt
GB9915231D0 (en) 1999-06-29 1999-09-01 Pfizer Ltd Pharmaceutical complex
GB9923314D0 (en) 1999-10-01 1999-12-08 Pfizer Ltd Acylation process
CA2324116A1 (en) * 1999-10-25 2001-04-25 Susan Beth Sobolov-Jaynes Nk-1 receptor antagonists and eletriptan for the treatment of migraine
US7108970B2 (en) 2000-01-07 2006-09-19 Transform Pharmaceuticals, Inc. Rapid identification of conditions, compounds, or compositions that inhibit, prevent, induce, modify, or reverse transitions of physical state
US6977723B2 (en) 2000-01-07 2005-12-20 Transform Pharmaceuticals, Inc. Apparatus and method for high-throughput preparation and spectroscopic classification and characterization of compositions
GB0008563D0 (en) 2000-04-07 2000-05-24 Cambridge Discovery Chemistry Investigating different physical and/or chemical forms of materials
GB0018968D0 (en) * 2000-08-02 2000-09-20 Pfizer Ltd Particulate composition
US20030166704A1 (en) * 2000-12-20 2003-09-04 Pfizer Inc. New process
US6579898B2 (en) 2001-03-01 2003-06-17 Pfizer Inc. Compositions having improved bioavailability
MXPA05010070A (es) 2003-04-11 2005-11-23 Pfizer Combinacion farmaceutica.
US7132549B2 (en) 2003-05-30 2006-11-07 Pfizer Inc. Process
GB0312478D0 (en) * 2003-05-30 2003-07-09 Pfizer Ltd Improved process
US6927296B2 (en) 2003-07-23 2005-08-09 Pfizer Inc. Process
GB0317229D0 (en) * 2003-07-23 2003-08-27 Pfizer Ltd Improved process
WO2007002597A2 (en) * 2005-06-27 2007-01-04 Biovail Laboratories International S.R.L. Modified-release formulations of a bupropion salt
EP2081893B1 (en) * 2006-10-19 2011-03-23 Auspex Pharmaceuticals, Inc. Substituted indoles
US20080139510A1 (en) * 2006-12-07 2008-06-12 Abe Rose Treatment of migraine headaches with sublingual amino acids
EP1956018A1 (de) * 2007-02-06 2008-08-13 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Herstellung eines Benzimidazolderivats
EP2093224A1 (en) * 2007-05-01 2009-08-26 Plus Chemicals B.V. Process for preparing eletriptan hydrobromide form beta
US20080319205A1 (en) * 2007-05-29 2008-12-25 Roman Bednar Process for preparing 5-bromo-3-[(R)-1-methyl-pyrrolidin-2-ylmethyl]-1H-indole
US20100285075A1 (en) * 2007-12-17 2010-11-11 Actavis Group Ptc Ehf Novel Hemioxalate Salt of Eletriptan
US20090299077A1 (en) * 2008-05-22 2009-12-03 Vinod Kumar Kansal Salts of (R)-5-(2phenylsulphonylethenyl)-3-(N-methylpyrrolidin-2-ylmethyl)-1H-indole, 5-bromo-3-[(R)-1-methyl-pyrrolidin-2-ylmethyl]-1H-indole and of eletriptan
US8349900B2 (en) 2008-08-07 2013-01-08 Valeant International Bermuda Bupropion hydrobromide polymorphs
US20120027816A1 (en) * 2009-02-25 2012-02-02 Actavis Group Ptc Ehf Highly pure eletriptan or a pharmaceutically acceptable salt thereof substantially free of eletriptan n-oxide impurity
WO2010116386A2 (en) * 2009-04-08 2010-10-14 Biophore India Pharmaceuticals Pvt. Ltd. Novel polymorph of eletriptan hydrobromide and process for the preparation thereof
IT1393700B1 (it) 2009-04-22 2012-05-08 F S I Fabbrica Italiana Sint Sintesi di 3-{[(2r)-1-metilpirrolidin-2-il]metil}-5-[2-(fenilsulfonil)etil]-1h-indolo
WO2011004391A2 (en) * 2009-06-25 2011-01-13 Matrix Laboratories Ltd An improved process for the preparation of eletriptan and its salt thereof
US8754239B2 (en) 2010-01-19 2014-06-17 Sms Pharmaceuticals Limited Process for preparing eletriptan hydrobromide having α-form
WO2014063752A1 (en) 2012-10-26 2014-05-01 Synthon Bv Process for making crystalline form alpha of eletriptan hydrobromide
JP2019502761A (ja) 2016-01-21 2019-01-31 ラボラトリオス レヴィ エセエレ （（ｒ）−３−［（−１−メチルピロリジン−２−イル）メチル］−５−（２−フェニルスルホニルエチル）−１ｈ−インドールを作製する方法

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2773875A (en) * 1952-03-28 1956-12-11 Hoffmann La Roche Indole derivatives and method for producing same
GB886684A (en) * 1957-09-17 1962-01-10 Upjohn Co Improvements in or relating to heterocyclic compounds and the manufacture thereof
GB851780A (en) * 1958-02-25 1960-10-19 Rhone Poulenc Sa New indole derivatives
US3037031A (en) * 1959-08-04 1962-05-29 Warner Lambert Pharmaceutical Derivatives of 3-(2-aminoalkyl)-5-indolol and process therefor
GB893707A (en) * 1960-03-01 1962-04-11 Roche Products Ltd Novel tryptamine derivatives and a process for the manufacture thereof
GB966562A (en) * 1961-04-06 1964-08-12 Parke Davis & Co Amine compounds and means of producing the same
US4092315A (en) * 1976-03-01 1978-05-30 Pfizer Inc. Novel crystalline forms of prazosin hydrochloride
ZA795239B (en) * 1978-10-12 1980-11-26 Glaxo Group Ltd Heterocyclic compounds
ZW19381A1 (en) * 1980-08-12 1983-03-09 Glaxo Group Ltd Heterocyclic compounds
US4803218A (en) * 1982-09-29 1989-02-07 Mcneilab, Inc. 3-aminoalkyl-1H-indole-5-urea and amide derivatives
GB8600397D0 (en) * 1986-01-08 1986-02-12 Glaxo Group Ltd Chemical compounds
DK158590D0 (da) * 1990-07-02 1990-07-02 Lundbeck & Co As H Indolderivater
US5559129A (en) * 1990-10-15 1996-09-24 Pfizer Inc Indole derivatives
US5578612A (en) * 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
US5559246A (en) * 1990-10-15 1996-09-24 Pfizer Inc. Indole derivatives
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
CA2091562C (en) * 1990-10-15 2001-03-27 John Eugene Macor Indole derivatives useful in psychotherapeutics
US5208248A (en) * 1991-01-11 1993-05-04 Merck Sharpe & Dohme, Ltd. Indazole-substituted five-membered heteroaromatic compounds
CZ283018B6 (cs) * 1991-02-01 1997-12-17 Merck Sharp And Dohme Limited Deriváty imidazolu, triazolu a tetrazolu a farmaceutické přípravky na jejich bázi
WO1993011106A1 (en) * 1991-11-25 1993-06-10 Pfizer, Inc. Indole derivatives
GB9201038D0 (en) * 1992-01-16 1992-03-11 Glaxo Group Ltd Chemical compounds
US5409941A (en) * 1992-02-03 1995-04-25 Pfizer Inc. 5-heteroyl indole derivatives
TW288010B (zh) * 1992-03-05 1996-10-11 Pfizer
CZ281763B6 (cs) * 1992-04-07 1997-01-15 Pfizer Inc. Indolové deriváty představující 5-HT1 agonisty, způsob jejich přípravy, farmaceutické prostředky obsahující tyto látky, jejich použití a meziprodukty postupu přípravy
ATE148465T1 (de) * 1992-04-10 1997-02-15 Pfizer Acylaminoindolderivate als 5-ht1 agonisten
GB9207930D0 (en) * 1992-04-10 1992-05-27 Pfizer Ltd Indoles
GB9208161D0 (en) * 1992-04-14 1992-05-27 Pfizer Ltd Indoles
GB9210400D0 (en) * 1992-05-15 1992-07-01 Merck Sharp & Dohme Therapeutic agents
FR2701026B1 (fr) * 1993-02-02 1995-03-31 Adir Nouveaux dérivés de l'indole, de l'indazole et du benzisoxazole, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
EP0695301B1 (en) * 1993-04-22 1996-10-30 Pfizer Limited Indole derivatives as 5-ht1-like agonists for use in migraine
AP486A (en) * 1993-04-27 1996-04-16 Pfizer Indole derivatives.
CZ59996A3 (en) * 1993-08-31 1996-06-12 Pfizer 5-arylindole derivatives per se and for treating diseases, intermediates for their preparation and pharmaceutical compositions based thereon

Also Published As

Publication number Publication date
RU2159241C2 (ru) 2000-11-20
OA10600A (en) 2000-04-06
BRPI9503812B1 (pt) 2017-04-18
HUT77310A (hu) 1998-03-30
ATE163182T1 (de) 1998-02-15
EG23822A (en) 2007-09-19
TR199501061A2 (tr) 1996-06-21
CZ56397A3 (cs) 1998-05-13
EP0776323B1 (en) 1998-02-11
FI113768B (fi) 2004-06-15
DZ1923A1 (fr) 2002-02-17
JPH09512283A (ja) 1997-12-09
HRP950460B1 (en) 2000-02-29
EP0776323A1 (en) 1997-06-04
PL180867B1 (pl) 2001-04-30
GB9417310D0 (en) 1994-10-19
BG101250A (en) 1997-09-30
IS4401A (is) 1996-12-19
SK282922B6 (sk) 2003-01-09
MA23650A1 (fr) 1996-04-01
AU2735295A (en) 1996-03-22
MX9701538A (es) 1997-05-31
US6380226B1 (en) 2002-04-30
IL115013A (en) 2000-11-21
YU49287B (sh) 2005-03-15
SI9520091A (sl) 1998-02-28
GR3026475T3 (en) 1998-06-30
CO4410334A1 (es) 1997-01-09
PE41596A1 (es) 1996-10-12
CZ287693B6 (en) 2001-01-17
IS1850B (is) 2003-02-07
ES2112650T3 (es) 1998-04-01
BR9503812A (pt) 1996-04-16
FI970800A (fi) 1997-02-26
WO1996006842A1 (en) 1996-03-07
HRP950460A2 (en) 1997-08-31
DE69501620T2 (de) 1998-07-02
LV11800B (en) 1997-10-20
ZA957142B (en) 1997-02-25
CN1066727C (zh) 2001-06-06
KR970705557A (ko) 1997-10-09
IL115013A0 (en) 1995-12-08
UA45980C2 (uk) 2002-05-15
NO970861D0 (no) 1997-02-26
CA2198599A1 (en) 1996-03-07
BG61840B1 (bg) 1998-07-31
US6110940A (en) 2000-08-29
SA95160156B1 (ar) 2005-05-30
YU56995A (sh) 1998-07-10
DE69501620D1 (de) 1998-03-19
NO970861L (no) 1997-02-26
KR100228952B1 (ko) 1999-11-01
LV11800A (lv) 1997-06-20
TNSN95092A1 (fr) 1996-02-06
AU691005B2 (en) 1998-05-07
FI970800A0 (fi) 1997-02-26
CN1155886A (zh) 1997-07-30
HU227822B1 (en) 2012-03-28
SK24897A3 (en) 1998-08-05
CA2198599C (en) 2000-06-06
AP9500754A0 (en) 1995-07-31
JP2904588B2 (ja) 1999-06-14
NZ288210A (en) 1998-01-26
RO116400B1 (ro) 2001-01-30
MY113733A (en) 2002-05-31
SI9520091B (sl) 2004-10-31
AP576A (en) 1997-03-20
NO311297B1 (no) 2001-11-12
PL318319A1 (en) 1997-06-09

Similar Documents

Publication Publication Date Title
DK0776323T3 (da) Salte af et indolderivat mod migræne
DK0900088T3 (da) Inklusionskomplekser af arylheterocykliske salte
DK1042287T3 (da) Indolderivater som inhibitorer af faktor Xa
DE69716615D1 (de) Heterozyklische metalloproteaseinhibitoren
FI962800A (fi) Fenyyliheterosyklisiä yhdisteitä COX-2 inhibiittoreina
BR9700885A (pt) Novas oxazolidinonas substituídas
DK0788496T3 (da) Inhibitorer for syntese af apolipoprotein-B
EE9600095A (et) Indooli derivaadid kui 5-HT agonistid
BR9510028A (pt) Compostos N-arílicos heterocíclicos substituídos contendo nitrogênio
DE69814685D1 (de) Indolderivate als PKC-Inhibitoren
DE60018619D1 (de) Befestigung rotierender Teile
DE69700616T2 (de) Imid derivate
FI973604A (fi) Äänilähdejärjestely
ATE214063T1 (de) Heterocyclische substituierte pyrrolidinamid- derivate
FI951047A0 (fi) Menetelmä indolijohdannaisten valmistamiseksi
DE59511029D1 (de) Tonwiedergabeanordnung
KR960016486U (ko) 진동발생장치
KR960032995U (ko) 캠코더의 나레이션 더빙장치
KR960015739U (ko) 전원 공급 장치의 클램핑 회로
KR960006659U (ko) 스피커용 진동부
KR970046152U (ko) 휴대형 씨디 플레이어의 전원 제어장치
KR950033390U (ko) 진동발생 장치
KR960015946U (ko) 레이져 트리머의 양면 부품용 척
KR970050269U (ko) 컴팩트 디스크 드라이브의 디스크 장착장치
SE9604089D0 (sv) Ljudalstrare drivmetod